Tofacitinib, an Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: Year 2 Efficacy and Safety Results From a 24-Month Phase 3 Study

D. van der Heijde,Y. Tanaka, R. M. Fleischmann, E. Keystone, J. M. Kremer,C. Zerbini, M. H. Cardiel,S. B. Cohen, P. T. Nash,Y. Song,D. Tegzova, B. Wyman, D. Gruben, B. Benda, G. Wallenstein, S. Krishnaswami, S. H. Zwillich,J. Bradley, C. A. Connell

ARTHRITIS AND RHEUMATISM(2012)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要